Review




Structured Review

List Biological Laboratories 200 ng ptx
200 Ng Ptx, supplied by List Biological Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+ptx/pmc11601571-211-10-11
Average 90 stars, based on 1 article reviews
200 ng ptx - by Bioz Stars, 2026-09
90/100 stars

Images



Similar Products

90
List Biological Laboratories 200 ng ptx
200 Ng Ptx, supplied by List Biological Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+ptx/pmc11601571-211-10-11
Average 90 stars, based on 1 article reviews
200 ng ptx - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Enzo Biochem pertussis toxin (ptx, 200 ng in 0.2 ml of ddh2o
Pertussis Toxin (Ptx, 200 Ng In 0.2 Ml Of Ddh2o, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/pertussis+toxin++ptx++200+ng+in+0+2+ml+of+ddh2o/pm38242900-285-7-17
Average 90 stars, based on 1 article reviews
pertussis toxin (ptx, 200 ng in 0.2 ml of ddh2o - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore pertussis toxin (ptx, 12.5− 200 ng/ mouse in 0.1 ml pbs
Pertussis Toxin (Ptx, 12.5− 200 Ng/ Mouse In 0.1 Ml Pbs, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/ptx/pm33189793-48-0-11
Average 90 stars, based on 1 article reviews
pertussis toxin (ptx, 12.5− 200 ng/ mouse in 0.1 ml pbs - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore 200 ng ptx
200 Ng Ptx, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+ptx/pmc07456214-486-17-18
Average 90 stars, based on 1 article reviews
200 ng ptx - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Hooke Laboratories ptx (200 ng in 0.1 ml)
Ptx (200 Ng In 0.1 Ml), supplied by Hooke Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/ptx++200+ng+in+0+1+ml+/us10751414-4992-9-15
Average 90 stars, based on 1 article reviews
ptx (200 ng in 0.1 ml) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
List Biological Laboratories 200 ng of ptx
C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + CFA + <t>PTX,</t> MOG 35–55 + SP + CFA + PTX, or MOG 35–55 + Flu peptide + CFA + PTX. Spleen and LN cells were harvested from D10 PI mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from MOG immunized mice were co-cultured with APC from MOG immunized mice either in the (a) absence of CD8 + T cells or in the presence of CD8 + T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or (f) CD8 + T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled CD4 + T cells from MOG 35–55 + CFA + PTX immunized mice were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/ml). In addition (h) CTV labelled CD4 + T cells from OVA 329–337 CFA + PTX were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX immunized mice. 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution). Representative data from two independent experiments. C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + SP + CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were isolated, stained, enriched for CD8 + T cells with Miltenyi cell enrichment kit followed by FACS to CD44 + CD122 + Ly49 + (Ly49 + ) and CD44 + CD122 + Ly49 − (Ly49 − ) cells. Sorted Ly49 + and Ly49 − cells were adoptively transferred (8 million cells/animal) to C57BL/6J mice (n = 5 mice/group) at the time of MOG 35–55 + CFA + PTX immunization. (i) The clinical scores following adoptive transfer of Ly49 + and Ly49 − cells and MOG 35–55 + SP + CFA + PTX immunization were recorded, and the significance of differences between clinical courses was calculated by regression analysis with the two-way ANOVA followed by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean ± SEM. Representative data from two independent experiments. (j) In the wild-type, untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes in the vitreous. (k) After <t>subcutaneous</t> <t>injection</t> of IRBP (interphotoreceptor binding protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice with purified (n) CD8 + CD44 + CD122 + Ly49 + [Ly49 + ], (o) CD8 + CD44 + CD122 + Ly49 − [Ly49 − ] or (m) without CD8 + T cells from IRBP + SP immunized mice 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution).
200 Ng Of Ptx, supplied by List Biological Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+ptx/pmc07145319-210-15-16
Average 90 stars, based on 1 article reviews
200 ng of ptx - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore 200 ng/ml ptx
C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + CFA + <t>PTX,</t> MOG 35–55 + SP + CFA + PTX, or MOG 35–55 + Flu peptide + CFA + PTX. Spleen and LN cells were harvested from D10 PI mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from MOG immunized mice were co-cultured with APC from MOG immunized mice either in the (a) absence of CD8 + T cells or in the presence of CD8 + T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or (f) CD8 + T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled CD4 + T cells from MOG 35–55 + CFA + PTX immunized mice were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/ml). In addition (h) CTV labelled CD4 + T cells from OVA 329–337 CFA + PTX were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX immunized mice. 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution). Representative data from two independent experiments. C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + SP + CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were isolated, stained, enriched for CD8 + T cells with Miltenyi cell enrichment kit followed by FACS to CD44 + CD122 + Ly49 + (Ly49 + ) and CD44 + CD122 + Ly49 − (Ly49 − ) cells. Sorted Ly49 + and Ly49 − cells were adoptively transferred (8 million cells/animal) to C57BL/6J mice (n = 5 mice/group) at the time of MOG 35–55 + CFA + PTX immunization. (i) The clinical scores following adoptive transfer of Ly49 + and Ly49 − cells and MOG 35–55 + SP + CFA + PTX immunization were recorded, and the significance of differences between clinical courses was calculated by regression analysis with the two-way ANOVA followed by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean ± SEM. Representative data from two independent experiments. (j) In the wild-type, untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes in the vitreous. (k) After <t>subcutaneous</t> <t>injection</t> of IRBP (interphotoreceptor binding protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice with purified (n) CD8 + CD44 + CD122 + Ly49 + [Ly49 + ], (o) CD8 + CD44 + CD122 + Ly49 − [Ly49 − ] or (m) without CD8 + T cells from IRBP + SP immunized mice 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution).
200 Ng/Ml Ptx, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+ptx/pm24935929-113-10-13
Average 90 stars, based on 1 article reviews
200 ng/ml ptx - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Millipore 200 ng/ml of pertussis toxin (ptx)
C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + CFA + <t>PTX,</t> MOG 35–55 + SP + CFA + PTX, or MOG 35–55 + Flu peptide + CFA + PTX. Spleen and LN cells were harvested from D10 PI mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from MOG immunized mice were co-cultured with APC from MOG immunized mice either in the (a) absence of CD8 + T cells or in the presence of CD8 + T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or (f) CD8 + T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled CD4 + T cells from MOG 35–55 + CFA + PTX immunized mice were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/ml). In addition (h) CTV labelled CD4 + T cells from OVA 329–337 CFA + PTX were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX immunized mice. 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution). Representative data from two independent experiments. C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + SP + CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were isolated, stained, enriched for CD8 + T cells with Miltenyi cell enrichment kit followed by FACS to CD44 + CD122 + Ly49 + (Ly49 + ) and CD44 + CD122 + Ly49 − (Ly49 − ) cells. Sorted Ly49 + and Ly49 − cells were adoptively transferred (8 million cells/animal) to C57BL/6J mice (n = 5 mice/group) at the time of MOG 35–55 + CFA + PTX immunization. (i) The clinical scores following adoptive transfer of Ly49 + and Ly49 − cells and MOG 35–55 + SP + CFA + PTX immunization were recorded, and the significance of differences between clinical courses was calculated by regression analysis with the two-way ANOVA followed by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean ± SEM. Representative data from two independent experiments. (j) In the wild-type, untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes in the vitreous. (k) After <t>subcutaneous</t> <t>injection</t> of IRBP (interphotoreceptor binding protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice with purified (n) CD8 + CD44 + CD122 + Ly49 + [Ly49 + ], (o) CD8 + CD44 + CD122 + Ly49 − [Ly49 − ] or (m) without CD8 + T cells from IRBP + SP immunized mice 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution).
200 Ng/Ml Of Pertussis Toxin (Ptx), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/200+ng+ptx/200+ng+pertussis+toxin/pmc04191899-141-20-23
Average 90 stars, based on 1 article reviews
200 ng/ml of pertussis toxin (ptx) - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + CFA + PTX, MOG 35–55 + SP + CFA + PTX, or MOG 35–55 + Flu peptide + CFA + PTX. Spleen and LN cells were harvested from D10 PI mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from MOG immunized mice were co-cultured with APC from MOG immunized mice either in the (a) absence of CD8 + T cells or in the presence of CD8 + T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or (f) CD8 + T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled CD4 + T cells from MOG 35–55 + CFA + PTX immunized mice were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/ml). In addition (h) CTV labelled CD4 + T cells from OVA 329–337 CFA + PTX were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX immunized mice. 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution). Representative data from two independent experiments. C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + SP + CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were isolated, stained, enriched for CD8 + T cells with Miltenyi cell enrichment kit followed by FACS to CD44 + CD122 + Ly49 + (Ly49 + ) and CD44 + CD122 + Ly49 − (Ly49 − ) cells. Sorted Ly49 + and Ly49 − cells were adoptively transferred (8 million cells/animal) to C57BL/6J mice (n = 5 mice/group) at the time of MOG 35–55 + CFA + PTX immunization. (i) The clinical scores following adoptive transfer of Ly49 + and Ly49 − cells and MOG 35–55 + SP + CFA + PTX immunization were recorded, and the significance of differences between clinical courses was calculated by regression analysis with the two-way ANOVA followed by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean ± SEM. Representative data from two independent experiments. (j) In the wild-type, untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes in the vitreous. (k) After subcutaneous injection of IRBP (interphotoreceptor binding protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice with purified (n) CD8 + CD44 + CD122 + Ly49 + [Ly49 + ], (o) CD8 + CD44 + CD122 + Ly49 − [Ly49 − ] or (m) without CD8 + T cells from IRBP + SP immunized mice 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution).

Journal: Nature

Article Title: Opposing T Cell Responses in Experimental Autoimmune Encephalomyelitis

doi: 10.1038/s41586-019-1467-x

Figure Lengend Snippet: C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + CFA + PTX, MOG 35–55 + SP + CFA + PTX, or MOG 35–55 + Flu peptide + CFA + PTX. Spleen and LN cells were harvested from D10 PI mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from MOG immunized mice were co-cultured with APC from MOG immunized mice either in the (a) absence of CD8 + T cells or in the presence of CD8 + T cells from (b) MOG + SP, (b) WT, (d) CFA + PTX, (e) MOG + flu, or (f) CD8 + T cells from Perforin knockout mice immunized with MOG + SP. (g) CTV labelled CD4 + T cells from MOG 35–55 + CFA + PTX immunized mice were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX in the presence of anti-Qa-1b antibody (10 ug/ml). In addition (h) CTV labelled CD4 + T cells from OVA 329–337 CFA + PTX were co-cultured with CD8 + T cells from MOG 35–55 + SP + CFA + PTX immunized mice. 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution). Representative data from two independent experiments. C57BL/6J mice were immunized with an emulsion containing MOG 35–55 + SP + CFA + PTX (n = 10) and 10 days post-immunization spleen and lymph node cells were isolated, stained, enriched for CD8 + T cells with Miltenyi cell enrichment kit followed by FACS to CD44 + CD122 + Ly49 + (Ly49 + ) and CD44 + CD122 + Ly49 − (Ly49 − ) cells. Sorted Ly49 + and Ly49 − cells were adoptively transferred (8 million cells/animal) to C57BL/6J mice (n = 5 mice/group) at the time of MOG 35–55 + CFA + PTX immunization. (i) The clinical scores following adoptive transfer of Ly49 + and Ly49 − cells and MOG 35–55 + SP + CFA + PTX immunization were recorded, and the significance of differences between clinical courses was calculated by regression analysis with the two-way ANOVA followed by Bonferroni post hoc multiple comparison test. **** p < 0.0001. Data are shown as mean ± SEM. Representative data from two independent experiments. (j) In the wild-type, untreated mouse eye, the retina shows a normal laminar pattern and there are no leukocytes in the vitreous. (k) After subcutaneous injection of IRBP (interphotoreceptor binding protein) peptide antigen, there was only a mild inflammatory response in 40% of eyes with activated leukocyte invasion of the vitreous (red arrow) and mild disruption of the and retina outer nuclear layer photoreceptors (black arrow). (l) Following subcutaneous injection of both IRBP + SP there was a severe inflammatory response in 80% of eyes with activated leukocyte invasion of the vitreous (red arrows) and severe disruption of the retina photoreceptors (black arrows). (RGC, retinal ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; RPE, retinal plexiform layer). Five C57BL/6J mice were examined for each condition. EAU was induced in mice and mice were euthanized on day 21 post-immunization. Mouse eyes were enucleated, fixed, and pupil-optic nerve sections were examined by histology. C57BL/6J mice were immunized with an emulsion containing IRBP + CFA + PTX or IRBP + SP + CFA + PTX. Spleen and LN cells were harvested from Day 10 post-immunized mice, enriched for either CD4 + , CD8 + T cells, or antigen presenting cells (APC) using Miltenyi cell enrichment kits followed by FACS. CellTraceTM Violet (CTV) Dye labelled CD4 + T cells from IRBP immunized mice were co-cultured with APC from IRBP immunized mice with purified (n) CD8 + CD44 + CD122 + Ly49 + [Ly49 + ], (o) CD8 + CD44 + CD122 + Ly49 − [Ly49 − ] or (m) without CD8 + T cells from IRBP + SP immunized mice 7 days post co-culture, cells were washed and stained with surface markers and analyzed for CD4 + T cell proliferation (CTV Dye dilution).

Article Snippet: On the day of immunization and 2 days post-immunization, each mouse received 200 ng of PTX (List Biological Laboratories, 180) by intraperitoneal injection.

Techniques: Cell Culture, Knock-Out, Co-Culture Assay, Staining, Isolation, Adoptive Transfer Assay, Injection, Binding Assay, Purification